2-((2,4-dichlorophenyl)amino)-N-(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1H-pyrazol-5-yl)acetamide

ID: ALA5190916

Chembl Id: CHEMBL5190916

PubChem CID: 168286468

Max Phase: Preclinical

Molecular Formula: C16H18Cl2N4O3S

Molecular Weight: 417.32

Names and Identifiers

Canonical SMILES:  Cc1cc(NC(=O)CNc2ccc(Cl)cc2Cl)n(C2CCS(=O)(=O)C2)n1

Standard InChI:  InChI=1S/C16H18Cl2N4O3S/c1-10-6-15(22(21-10)12-4-5-26(24,25)9-12)20-16(23)8-19-14-3-2-11(17)7-13(14)18/h2-3,6-7,12,19H,4-5,8-9H2,1H3,(H,20,23)

Standard InChI Key:  CVMIMDMAWXUFEM-UHFFFAOYSA-N

Alternative Forms

1. Parent:

   

   ALA5190916

   ---

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 417.32

Molecular Weight (Monoisotopic): 416.0477

AlogP: 2.91

#Rotatable Bonds: 5

Polar Surface Area: 93.09

Molecular Species: NEUTRAL

HBA: 6

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 7

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 12.87

CX Basic pKa: 3.12

CX LogP: 1.00

CX LogD: 0.99

Aromatic Rings: 2

Heavy Atoms: 26

QED Weighted: 0.78

Np Likeness Score: -2.87

References

1. Sharma S, Lesiak L, Aretz CD, Du Y, Kumar S, Gautam N, Alnouti Y, Dhuria NV, Chhonker YS, Weaver CD, Hopkins CR..  (2021)  Discovery, synthesis and biological characterization of a series of N-(1-(1,1-dioxidotetrahydrothiophen-3-yl)-3-methyl-1H-pyrazol-5-yl)acetamide ethers as novel GIRK1/2 potassium channel activators.,  12  (8.0): [PMID:34458739] [10.1039/D1MD00129A]

Source

Source(1):

• Scientific Literature